X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with Merck Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs MERCK LTD - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

MERCK LTD 
   Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA MERCK LTD TORRENT PHARMA/
MERCK LTD
 
P/E (TTM) x 25.8 26.1 98.9% View Chart
P/BV x 6.3 2.9 216.3% View Chart
Dividend Yield % 3.2 1.0 326.5%  

Financials

 TORRENT PHARMA   MERCK LTD
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
MERCK LTD
Dec-16
TORRENT PHARMA/
MERCK LTD
5-Yr Chart
Click to enlarge
High Rs1,7201,060 162.3%   
Low Rs1,134623 181.9%   
Sales per share (Unadj.) Rs394.5632.4 62.4%  
Earnings per share (Unadj.) Rs101.845.7 222.6%  
Cash flow per share (Unadj.) Rs116.362.3 186.7%  
Dividends per share (Unadj.) Rs40.0011.00 363.6%  
Dividend yield (eoy) %2.81.3 214.5%  
Book value per share (Unadj.) Rs200.3388.8 51.5%  
Shares outstanding (eoy) m169.2216.60 1,019.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.61.3 271.8%   
Avg P/E ratio x14.018.4 76.2%  
P/CF ratio (eoy) x12.313.5 90.8%  
Price / Book Value ratio x7.12.2 329.2%  
Dividend payout %39.324.1 163.3%   
Avg Mkt Cap Rs m241,43513,969 1,728.4%   
No. of employees `00010.91.6 688.1%   
Total wages/salary Rs m8,5591,487 575.7%   
Avg. sales/employee Rs Th6,129.66,631.9 92.4%   
Avg. wages/employee Rs Th785.8939.2 83.7%   
Avg. net profit/employee Rs Th1,581.3479.4 329.9%   
INCOME DATA
Net Sales Rs m66,76410,498 635.9%  
Other income Rs m2,156242 889.6%   
Total revenues Rs m68,92010,741 641.7%   
Gross profit Rs m27,2041,135 2,396.2%  
Depreciation Rs m2,461276 893.1%   
Interest Rs m1,8590-   
Profit before tax Rs m25,0411,102 2,271.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1,4030-   
Tax Rs m6,414343 1,868.3%   
Profit after tax Rs m17,224759 2,269.6%  
Gross profit margin %40.710.8 376.8%  
Effective tax rate %25.631.1 82.2%   
Net profit margin %25.87.2 356.9%  
BALANCE SHEET DATA
Current assets Rs m46,6226,410 727.4%   
Current liabilities Rs m32,8438,828 372.0%   
Net working cap to sales %20.6-23.0 -89.6%  
Current ratio x1.40.7 195.5%  
Inventory Days Days7458 128.7%  
Debtors Days Days7938 205.8%  
Net fixed assets Rs m39,0291,406 2,775.1%   
Share capital Rs m846166 509.8%   
"Free" reserves Rs m31,4006,286 499.5%   
Net worth Rs m33,8906,455 525.1%   
Long term debt Rs m18,6370-   
Total assets Rs m90,1368,828 1,021.0%  
Interest coverage x14.5NM-  
Debt to equity ratio x0.50-  
Sales to assets ratio x0.71.2 62.3%   
Return on assets %21.28.6 246.3%  
Return on equity %50.811.8 432.3%  
Return on capital %48.517.1 284.3%  
Exports to sales %43.38.3 523.3%   
Imports to sales %6.921.0 32.6%   
Exports (fob) Rs m28,934869 3,328.1%   
Imports (cif) Rs m4,5842,209 207.5%   
Fx inflow Rs m29,185959 3,044.0%   
Fx outflow Rs m6,0212,612 230.5%   
Net fx Rs m23,165-1,653 -1,401.2%   
CASH FLOW
From Operations Rs m27,1321,070 2,534.8%  
From Investments Rs m-7,014-750 935.6%  
From Financial Activity Rs m-14,352-150 9,580.4%  
Net Cashflow Rs m5,767171 3,374.2%  

Share Holding

Indian Promoters % 71.5 0.0 -  
Foreign collaborators % 0.0 51.8 -  
Indian inst/Mut Fund % 7.0 18.2 38.6%  
FIIs % 12.6 1.0 1,260.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 29.1 30.2%  
Shareholders   26,511 28,591 92.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   ABBOTT INDIA  NATCO PHARMA  DIVIS LABORATORIES  PFIZER  ALEMBIC PHARMA  

Compare TORRENT PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Marginally Lower; IT Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the IT sector and power sector witnessing maximum selling pressure.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 21, 2017 12:56 PM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS